Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Major depressive disorder and immunity to varicella-zoster virus in the elderly.

Irwin MR, Levin MJ, Carrillo C, Olmstead R, Lucko A, Lang N, Caulfield MJ, Weinberg A, Chan IS, Clair J, Smith JG, Marchese RD, Williams HM, Beck DJ, McCook PT, Johnson G, Oxman MN.

Brain Behav Immun. 2011 May;25(4):759-66. doi: 10.1016/j.bbi.2011.02.001. Epub 2011 Feb 15.

2.

Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.

Irwin MR, Levin MJ, Laudenslager ML, Olmstead R, Lucko A, Lang N, Carrillo C, Stanley HA, Caulfield MJ, Weinberg A, Chan IS, Clair J, Smith JG, Marchese RD, Williams HM, Beck DJ, McCook PT, Zhang JH, Johnson G, Oxman MN.

Clin Infect Dis. 2013 Apr;56(8):1085-93. doi: 10.1093/cid/cis1208. Epub 2013 Feb 13.

3.

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Schödel F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ; US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators.

J Infect Dis. 2009 Oct 1;200(7):1068-77. doi: 10.1086/605611.

4.

Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.

Levin MJ, Schmader KE, Pang L, Williams-Diaz A, Zerbe G, Canniff J, Johnson MJ, Caldas Y, Cho A, Lang N, Su SC, Parrino J, Popmihajlov Z, Weinberg A.

J Infect Dis. 2016 Jan 1;213(1):14-22. doi: 10.1093/infdis/jiv480. Epub 2015 Oct 9.

PMID:
26452397
5.

Cellular immunity to varicella-zoster virus in patients with major depression.

Irwin M, Costlow C, Williams H, Artin KH, Chan CY, Stinson DL, Levin MJ, Hayward AR, Oxman MN.

J Infect Dis. 1998 Nov;178 Suppl 1:S104-8. Erratum in: J Infect Dis 1999 Mar;179(3):753.

PMID:
9852986
6.

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.

Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan IS, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A; Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators.

J Infect Dis. 2008 Mar 15;197(6):825-35. doi: 10.1086/528696.

7.

Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.

Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ.

J Infect Dis. 2003 Nov 1;188(9):1336-44. Epub 2003 Oct 17.

PMID:
14593591
8.

A community-based survey of varicella-zoster virus-specific immune responses in the elderly.

Tang H, Moriishi E, Okamoto S, Okuno Y, Iso H, Asada H, Yamanishi K, Mori Y; Shozu Herpes Zoster Study group.

J Clin Virol. 2012 Sep;55(1):46-50. Epub 2012 Jul 6.

PMID:
22771002
9.

Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.

Sullivan NL, Reuter-Monslow MA, Sei J, Durr E, Davis CW, Chang C, McCausland M, Wieland A, Krah D, Rouphael N, Mehta AK, Mulligan MJ, Pulendran B, Ahmed R, Vora KA.

J Virol. 2018 Jun 29;92(14). pii: e00269-18. doi: 10.1128/JVI.00269-18. Print 2018 Jul 15.

PMID:
29743372
10.

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.

Trannoy E, Berger R, Holländer G, Bailleux F, Heimendinger P, Vuillier D, Creusvaux H.

Vaccine. 2000 Feb 25;18(16):1700-6.

PMID:
10689152
11.

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Weinberg A, Lazar AA, Zerbe GO, Hayward AR, Chan IS, Vessey R, Silber JL, MacGregor RR, Chan K, Gershon AA, Levin MJ.

J Infect Dis. 2010 Apr 1;201(7):1024-30. doi: 10.1086/651199.

12.

Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.

Otani N, Yamanishi K, Sakaguchi Y, Imai Y, Shima M, Okuno T.

J Immunol Methods. 2012 Mar 30;377(1-2):53-5. doi: 10.1016/j.jim.2012.01.003. Epub 2012 Jan 12.

PMID:
22261191
13.

Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.

Rondaan C, de Haan A, Horst G, Hempel JC, van Leer C, Bos NA, van Assen S, Bijl M, Westra J.

Arthritis Rheumatol. 2014 Nov;66(11):3122-8. doi: 10.1002/art.38804.

14.

Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.

Shirane R, Tang H, Hayashi K, Okuno Y, Iso H, Asada H, Yamanishi K, Mori Y; SHEZ study group.

J Med Virol. 2017 Feb;89(2):313-317. doi: 10.1002/jmv.24629. Epub 2016 Jul 29.

PMID:
27420414
15.

Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects.

Tyring SK, Stek JE, Smith JG, Xu J, Pagnoni M, Chan IS, Silber JL, Parrino J, Levin MJ.

Clin Vaccine Immunol. 2012 Sep;19(9):1411-5. doi: 10.1128/CVI.00095-12. Epub 2012 Jul 11.

16.

Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial.

Hata A, Inoue F, Hamamoto Y, Yamasaki M, Fujikawa J, Kawahara H, Kawasaki Y, Honjo S, Koshiyama H, Moriishi E, Mori Y, Ohkubo T.

Diabet Med. 2016 Aug;33(8):1094-101. doi: 10.1111/dme.13038. Epub 2015 Dec 29.

PMID:
26605507
17.

Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.

De Castro N, Carmagnat M, Kernéis S, Scieux C, Rabian C, Molina JM.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1089-97. doi: 10.1089/AID.2010.0340. Epub 2011 May 4.

PMID:
21417759
18.

Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.

Schub D, Janssen E, Leyking S, Sester U, Assmann G, Hennes P, Smola S, Vogt T, Rohrer T, Sester M, Schmidt T.

J Infect Dis. 2015 Feb 15;211(4):600-12. doi: 10.1093/infdis/jiu500. Epub 2014 Sep 1.

PMID:
25180236
19.

Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.

Sadaoka K, Okamoto S, Gomi Y, Tanimoto T, Ishikawa T, Yoshikawa T, Asano Y, Yamanishi K, Mori Y.

J Infect Dis. 2008 Nov 1;198(9):1327-33. doi: 10.1086/592219.

PMID:
18774884
20.

An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.

Asada H, Nagayama K, Okazaki A, Mori Y, Okuno Y, Takao Y, Miyazaki Y, Onishi F, Okeda M, Yano S, Kumihashi H, Gomi Y, Maeda K, Ishikawa T, Iso H, Yamanishi K; Shozu Herpes Zoster (SHEZ) Study group.

J Dermatol Sci. 2013 Mar;69(3):243-9. doi: 10.1016/j.jdermsci.2012.10.015. Epub 2012 Nov 5.

PMID:
23183011

Supplemental Content

Support Center